What was BioNTech SE's revenue in 2022?

BioNTech SE reported $18.9B in revenue for fiscal year 2022. As the earliest year shown here, this marked a near-peak pandemic haul, with Pfizer-partnered Comirnaty COVID-19 vaccine sales still dominating the top line.

Was 2022 BioNTech SE's best revenue year?

Yes — 2022 was BioNTech SE's highest recorded revenue year at $18.9B, the peak across all 4 years of available data.

What was BioNTech SE's highest ever annual revenue?

BioNTech SE's highest ever annual revenue was $18.9B recorded in fiscal year 2022.

BioNTech SE Revenue in 2022: $18.9B

CorpDigest

Search companiesSearchK Contact

BioNTech SE

Biotechnology / ImmunotherapyFounded 2008

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Explore BioNTech SE

Core profile pages, annual revenue records, and related research hubs for this company.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.

CorpDigest

Year	Revenue	YoY Change
FY2025	$3.2B	+5.7%
FY2024	$3.0B	-27.9%
FY2023	$4.2B	-78.0%
FY2022	$18.9B	—

Year	Revenue	YoY Change
FY2025	$3.2B	+5.7%
FY2024	$3.0B	-27.9%
FY2023	$4.2B	-78.0%
FY2022	$18.9B	—

BioNTech SE Revenue in 2022

Revenue by Year

BioNTech SE Annual Revenue History

BioNTech SE Revenue in 2022

Revenue by Year

BioNTech SE Annual Revenue History